Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-02-24

Clinical Trial Update: Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes [NA]

View source ↗

Summary

Clinical trial investigating whether pomegranate supplementation reduces maternal/fetal oxidative stress and improves outcomes in pregnancies affected by preter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomegranate (Punica granatum extract)

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: PPROM | NA | Status: UNKNOWN